Your browser doesn't support javascript.
loading
Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
Guest, Stephanie K; Ribas, Ricardo; Pancholi, Sunil; Nikitorowicz-Buniak, Joanna; Simigdala, Nikiana; Dowsett, Mitch; Johnston, Stephen R; Martin, Lesley-Ann.
Affiliation
  • Guest SK; The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Ribas R; The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Pancholi S; The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Nikitorowicz-Buniak J; The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Simigdala N; The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Dowsett M; The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Johnston SR; Royal Marsden Hospital, London, United Kingdom.
  • Martin LA; Royal Marsden Hospital, London, United Kingdom.
PLoS One ; 11(6): e0157397, 2016.
Article in En | MEDLINE | ID: mdl-27308830

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Estrogen / Gene Expression Regulation, Neoplastic / Src-Family Kinases / Drug Resistance, Neoplasm / Antineoplastic Agents, Hormonal / Dasatinib Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: PLoS One Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Estrogen / Gene Expression Regulation, Neoplastic / Src-Family Kinases / Drug Resistance, Neoplasm / Antineoplastic Agents, Hormonal / Dasatinib Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: PLoS One Year: 2016 Document type: Article